Analysts Set Kenvue Inc. (NYSE:KVUE) PT at $20.23

Shares of Kenvue Inc. (NYSE:KVUE) have received a consensus recommendation of “Hold” from the eighteen research firms that are covering the company, Marketbeat.com reports. Twelve research analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $20.2333.

KVUE has been the subject of a number of recent research reports. Edward Jones lowered shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 3rd. Barclays raised their target price on shares of Kenvue from $17.00 to $18.00 and gave the stock an “equal weight” rating in a report on Monday, November 10th. UBS Group lowered their price target on shares of Kenvue from $23.00 to $17.00 and set a “neutral” rating on the stock in a report on Wednesday, October 8th. JPMorgan Chase & Co. cut their price target on Kenvue from $24.00 to $21.00 and set an “overweight” rating on the stock in a research report on Friday, October 10th. Finally, Jefferies Financial Group decreased their price objective on Kenvue from $25.00 to $23.00 and set a “buy” rating for the company in a report on Monday, October 27th.

Kenvue Stock Performance

Shares of KVUE opened at $16.82 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98. The stock has a 50-day moving average of $16.90 and a two-hundred day moving average of $18.40. The stock has a market cap of $32.22 billion, a P/E ratio of 22.42 and a beta of 0.60. Kenvue has a one year low of $14.02 and a one year high of $25.17.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.01. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The firm had revenue of $3.76 billion during the quarter, compared to analysts’ expectations of $3.83 billion. During the same period last year, the business posted $0.28 earnings per share. The company’s revenue for the quarter was down 3.5% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, research analysts predict that Kenvue will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, November 26th. Investors of record on Wednesday, November 12th were given a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a yield of 4.9%. The ex-dividend date was Wednesday, November 12th. Kenvue’s dividend payout ratio (DPR) is currently 110.67%.

Insider Buying and Selling

In other news, Director Jeffrey C. Smith acquired 3,200,000 shares of the company’s stock in a transaction dated Friday, December 12th. The shares were acquired at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the purchase, the director directly owned 27,307,632 shares of the company’s stock, valued at $474,333,567.84. This trade represents a 13.27% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.68% of the company’s stock.

Institutional Trading of Kenvue

A number of hedge funds have recently added to or reduced their stakes in the company. Salomon & Ludwin LLC purchased a new position in Kenvue in the third quarter valued at $25,000. NBT Bank N A NY grew its position in shares of Kenvue by 180.3% during the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after acquiring an additional 1,006 shares during the period. Cornerstone Planning Group LLC increased its stake in shares of Kenvue by 705.2% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock valued at $25,000 after purchasing an additional 1,361 shares in the last quarter. Golden State Wealth Management LLC increased its stake in shares of Kenvue by 150.1% in the 3rd quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock valued at $32,000 after purchasing an additional 1,190 shares in the last quarter. Finally, Trust Co. of Vermont boosted its position in Kenvue by 266.8% during the second quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock worth $33,000 after purchasing an additional 1,150 shares in the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.